It was reported that patients with GH-producing pituitary adenomas and a tumor-stimulatory G protein (gsp) mutation had small tumor volume with a higher rate of TRH responders [17, 18], which provided a theoretical background for inverse correlation between the GH response to TRH and tumor volume [16]. Here, GH1 is linked to neoplasm.